TipRanks
Go Ultimate55% OFF

Compare STRATEC Biomedical (SBS) vs. Competitors

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
DE:SBSSTRATEC BiomedicalEUR 23.90EUR 273.51M-562.501.91%Moderate BuyUnlock the DE:SBS analyst price target with TipRanks PremiumDE:SBSUnlock the DE:SBS top-analyst price target with TipRanks Premium
DE:DRW8Draegerwerk AG & Co. KGaAEUR 74.80EUR 1.64B11.2822.95%―Unlock the DE:DRW8 analyst price target with TipRanks PremiumDE:SBS vs DE:DRW8Unlock the DE:DRW8 top-analyst price target with TipRanks Premium
DE:EUZEckert & Ziegler Strahlen und MedizintechnikEUR 13.37EUR 832.23M16.63-20.44%Moderate BuyUnlock the DE:EUZ analyst price target with TipRanks PremiumDE:SBS vs DE:EUZUnlock the DE:EUZ top-analyst price target with TipRanks Premium
DE:SISFirst SensorEUR 53.50EUR 563.45M39.78-5.59%―Unlock the DE:SIS analyst price target with TipRanks PremiumDE:SBS vs DE:SISUnlock the DE:SIS top-analyst price target with TipRanks Premium
DE:GXIGerresheimerEUR 32.56EUR 1.11B-2.7618.19%NeutralUnlock the DE:GXI analyst price target with TipRanks PremiumDE:SBS vs DE:GXIUnlock the DE:GXI top-analyst price target with TipRanks Premium
DE:SHLSiemens Healthineers AGEUR 43.52EUR 47.86B21.66-10.64%Strong BuyUnlock the DE:SHL analyst price target with TipRanks PremiumDE:SBS vs DE:SHLUnlock the DE:SHL top-analyst price target with TipRanks Premium

Performance Comparison

-50%-25%0%25%50%75%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
DE:SBSSTRATEC Biomedical23.951.004.36%
DE:DRW8Draegerwerk AG & Co. KGaA75.0015.4826.00%
DE:EUZEckert & Ziegler Strahlen und Medizintechnik13.47-2.92-17.84%
DE:SISFirst Sensor54.00-2.32-4.12%
DE:GXIGerresheimer32.625.9622.36%
DE:SHLSiemens Healthineers AG43.40-4.27-8.96%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts